The aim of this study is to compare the complications according to the presence of ureteral stents or not. 200 consecutive patients who underwent robotic radical cystectomy for bladder cancer at our ...

At AUA 2025, Bayer will present new data highlighting NUBEQA® (darolutamide) across multiple stages of prostate cancer, including ultra-low PSA response data from the ARANOTE trial and a focused ...

There was a technical success rate of 99% for the stent placement procedure with a total of nine complications (6%). At follow-up (mean 22.3 months), 88% of patients experienced improvement in ...